Payment overview · 2025
General Payments
$8.92
1 reported records · 1 companies
Healthcare provider profile · identity verified
Jonathan Scott Clark, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · POTEAU, OK · NPI 1184682866
Verified facts
What the public records show
CMS Open Payments records show Jonathan Scott Clark, D.O. received $8.92 in general payments during 2025 across 1 reported records.
Axsome Therapeutics, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $8.92 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $8.92 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $8.92 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 491 | 143 |
| Lisinopril | Lisinopril | 392 | 97 |
| Gabapentin | Gabapentin | 350 | 78 |
| Amlodipine Besylate | Amlodipine Besylate | 347 | 90 |
| Omeprazole | Omeprazole | 340 | 95 |
| Levothyroxine Sodium | Levothyroxine Sodium | 283 | 77 |
| Losartan Potassium | Losartan Potassium | 229 | 60 |
| Metoprolol Tartrate | Metoprolol Tartrate | 223 | 58 |
| Potassium Chloride | Potassium Chloride | 218 | 56 |
| Metformin Hcl | Metformin Hcl | 213 | 61 |
| Hydrochlorothiazide | Hydrochlorothiazide | 197 | 52 |
| Simvastatin | Simvastatin | 197 | 46 |
| Furosemide | Furosemide | 196 | 67 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 179 | 53 |
| Carvedilol | Carvedilol | 170 | 46 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 170 | 46 |
| Clopidogrel | Clopidogrel Bisulfate | 164 | 39 |
| Sertraline Hcl | Sertraline Hcl | 144 | 34 |
| Meloxicam | Meloxicam | 141 | 40 |
| Tamsulosin Hcl | Tamsulosin Hcl | 141 | 50 |
| Pantoprazole Sodium | Pantoprazole Sodium | 138 | 42 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 128 | 38 |
| Azithromycin | Azithromycin | 116 | 76 |
| Eliquis | Apixaban | 116 | 25 |
| Metoprolol Succinate | Metoprolol Succinate | 116 | 32 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 109 | 19 |
| Ozempic | Semaglutide | 107 | 21 |
| Zolpidem Tartrate | Zolpidem Tartrate | 107 | 22 |
| Pravastatin Sodium | Pravastatin Sodium | 106 | 28 |
| Ventolin Hfa | Albuterol Sulfate | 96 | 21 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 95 | 22 |
| Diclofenac Sodium | Diclofenac Sodium | 91 | 21 |
| Fluticasone Propionate | Fluticasone Propionate | 87 | 27 |
| Pregabalin | Pregabalin | 87 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 86 | 16 |
| Montelukast Sodium | Montelukast Sodium | 86 | 19 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 83 | 20 |
| Tramadol Hcl | Tramadol Hcl | 82 | 19 |
| Jardiance | Empagliflozin | 76 | 21 |
| Allopurinol | Allopurinol | 74 | 24 |
| Buspirone Hcl | Buspirone Hcl | 71 | 14 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 71 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 64 | 17 |
| Trazodone Hcl | Trazodone Hcl | 62 | 17 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 59 | 15 |
| Tizanidine Hcl | Tizanidine Hcl | 57 | 17 |
| Duloxetine Hcl | Duloxetine Hcl | 56 | 13 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 55 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 54 | 15 |
| Celecoxib | Celecoxib | 53 | 15 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 53 | 16 |
| Escitalopram Oxalate | Escitalopram Oxalate | 52 | 13 |
| Linzess | Linaclotide | 51 | 13 |
| Pioglitazone Hcl | Pioglitazone Hcl | 51 | 14 |
| Warfarin Sodium | Warfarin Sodium | 51 | 12 |
| Methylprednisolone | Methylprednisolone | 48 | 36 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 47 | 40 |
| Enalapril Maleate | Enalapril Maleate | 45 | 14 |
| Ibuprofen | Ibuprofen | 45 | 13 |
| Clonidine Hcl | Clonidine Hcl | 40 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 40 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 39 | 11 |
| Ondansetron Hcl | Ondansetron Hcl | 39 | 14 |
| Glipizide | Glipizide | 37 | 11 |
| Symbicort | Budesonide/Formoterol Fumarate | 37 | suppressed |
| Lovastatin | Lovastatin | 36 | suppressed |
| Mounjaro | Tirzepatide | 36 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 34 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 33 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 33 | suppressed |
| Alprazolam | Alprazolam | 32 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 32 | suppressed |
| Ondansetron Odt | Ondansetron | 32 | 16 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 30 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 30 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 30 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 30 | suppressed |
| Xarelto | Rivaroxaban | 30 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 29 | suppressed |
| Nystatin | Nystatin | 28 | 13 |
| Cephalexin | Cephalexin | 27 | 24 |
| Hydralazine Hcl | Hydralazine Hcl | 27 | suppressed |
| Januvia | Sitagliptin Phosphate | 27 | suppressed |
| Nitroglycerin | Nitroglycerin | 27 | 15 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 26 | 23 |
| Bupropion Hcl Sr | Bupropion Hcl | 26 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 25 | suppressed |
| Aripiprazole | Aripiprazole | 25 | suppressed |
| Atenolol | Atenolol | 25 | suppressed |
| Finasteride | Finasteride | 25 | suppressed |
| Glimepiride | Glimepiride | 25 | suppressed |
| Sucralfate | Sucralfate | 25 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 25 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 24 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 24 | suppressed |
| Famotidine | Famotidine | 24 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 24 | suppressed |
| Lorazepam | Lorazepam | 24 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 24 | suppressed |
| Mirtazapine | Mirtazapine | 24 | suppressed |
| Nifedipine Er | Nifedipine | 24 | suppressed |
| Topiramate | Topiramate | 24 | suppressed |
| Bumetanide | Bumetanide | 23 | suppressed |
| Estradiol | Estradiol | 23 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 23 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 23 | suppressed |
| Spironolactone | Spironolactone | 23 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 22 | suppressed |
| Ezetimibe | Ezetimibe | 21 | suppressed |
| Fluconazole | Fluconazole | 21 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 21 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 21 | 18 |
| Oxybutynin Chloride | Oxybutynin Chloride | 21 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 21 | suppressed |
| Torsemide | Torsemide | 21 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 20 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 20 | suppressed |
| Levetiracetam | Levetiracetam | 19 | suppressed |
| Colchicine | Colchicine | 18 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 17 | suppressed |
| Digoxin | Digoxin | 17 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 17 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 17 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 16 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 16 | suppressed |
| Temazepam | Temazepam | 16 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 15 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 15 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 15 | 12 |
| Doxepin Hcl | Doxepin Hcl | 15 | suppressed |
| Indomethacin | Indomethacin | 15 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 15 | suppressed |
| Methocarbamol | Methocarbamol | 15 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 15 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 14 | 12 |
| Jantoven | Warfarin Sodium | 14 | suppressed |
| Lamotrigine | Lamotrigine | 14 | suppressed |
| Mupirocin | Mupirocin | 14 | suppressed |
| Ranolazine Er | Ranolazine | 14 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 14 | suppressed |
| Verapamil Er | Verapamil Hcl | 14 | suppressed |
| Acyclovir | Acyclovir | 13 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 13 | suppressed |
| Dutasteride | Dutasteride | 13 | suppressed |
| Entresto | Sacubitril/Valsartan | 13 | suppressed |
| Etodolac | Etodolac | 13 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 13 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 13 | suppressed |
| Prednisone | Prednisone | 13 | suppressed |
| Telmisartan | Telmisartan | 13 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 13 | suppressed |
| Calcitriol | Calcitriol | 12 | suppressed |
| Easy Touch Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Eszopiclone | Eszopiclone | 12 | suppressed |
| Glipizide Er | Glipizide | 12 | suppressed |
| Glyburide | Glyburide | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 12 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 12 | suppressed |
| Multaq | Dronedarone Hcl | 12 | suppressed |
| Naproxen | Naproxen | 12 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 12 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 11 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 11 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $8.92 · 1 records | Axsome Therapeutics, Inc. | Auvelity | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error